로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > GFAP

GFAP

요약

Name:Glial fibrillary acidic protein
Target Synonym:Glial Fibrillary Acidic Protein,Intermediate Filament Protein,ALXDRD,FLJ45472
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

제품 리스트 구매

제품 상태별:
제품 유형별 :
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
GFP-S453 Rabbit Polyclonal GFAP Antibody, Rabbit IgG
GFP-H5143 Human Human GFAP Protein, His Tag
GFP-H5143-structure
GFP-H5143-sds
GFP-M5148 Mouse Mouse GFAP Protein, His Tag
GFP-M5148-structure
GFP-M5148-sds

일부의 생물활성 데이터

GFP-M5148-ELISA
 GFAP ELISA

Immobilized Mouse GFAP, His Tag (Cat. No. GFP-M5148) at 1 μg/mL (100 μL/well) can bind GFAP Monoclonal Antibody with a linear range of 0.4-25 ng/mL (Routinely tested).

GFP-H5143-ELISA
 GFAP ELISA

Immobilized Human GFAP, His Tag (Cat. No. GFP-H5143) at 1 μg/mL (100 μL/well) can bind GFAP Monoclonal Antibody with a linear range of 0.8-25 ng/mL (QC tested).

Synonym Name

Glial fibrillary acidic protein

Background

GFAP (Glial fibrillary acidic protein) is a monomeric intermediate filament protein fuond in mature astrocytes and other glial cells but is not found outside the CNS. Increased GFAP immunoreactivity (or astrocytic activation) is usually viewed as an index of gliosis or a relatively slow-developing correlate of neural damage.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Gastrodine Approved Kpc Pharmaceuticals Inc 辛基宁, 天眩清, 曲络彤, 丹彤 Mainland China Vertigo; Brain Injuries, Traumatic; Headache; Neurasthenia Kpc Pharmaceuticals Inc 2001-01-01 Headache; Vertigo; Brain Injuries, Traumatic; Neurasthenia Details
Gastrodine Approved Kpc Pharmaceuticals Inc 辛基宁, 天眩清, 曲络彤, 丹彤 Mainland China Vertigo; Brain Injuries, Traumatic; Headache; Neurasthenia Kpc Pharmaceuticals Inc 2001-01-01 Headache; Vertigo; Brain Injuries, Traumatic; Neurasthenia Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
ION-373 ION-373 Phase 3 Clinical Ionis Pharmaceuticals Inc Alexander Disease Details
ION-373 ION-373 Phase 3 Clinical Ionis Pharmaceuticals Inc Alexander Disease Details

This web search service is supported by Google Inc.

totop